Comparative Risk of Adverse Pancreatic Events With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas Among Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk. uri icon

authors

  • Kalathiya, Urja N
  • Mickelson, Mindy M
  • McCoy, Rozalina G
  • Herrin, Jeph
  • Swarna, Kavya Sindu
  • Deng, Yihong
  • Polley, Eric C
  • Neumiller, Joshua J
  • Galindo, Rodolfo J
  • Umpierrez, Guillermo E
  • Joseph S. Ross, MD, MHS

publication date

  • September 11, 2025